dc.contributor.author |
Wu, Li-Tzy |
|
dc.contributor.author |
Ghitza, Udi E |
|
dc.contributor.author |
Burns, Anne L |
|
dc.contributor.author |
Mannelli, Paolo |
|
dc.coverage.spatial |
New Zealand |
|
dc.date.accessioned |
2017-09-01T19:41:39Z |
|
dc.date.available |
2017-09-01T19:41:39Z |
|
dc.date.issued |
2017 |
|
dc.identifier |
https://www.ncbi.nlm.nih.gov/pubmed/28814912 |
|
dc.identifier |
sar-8-053 |
|
dc.identifier.issn |
1179-8467 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/15429 |
|
dc.language |
eng |
|
dc.publisher |
Informa UK Limited |
|
dc.relation.ispartof |
Subst Abuse Rehabil |
|
dc.relation.isversionof |
10.2147/SAR.S144268 |
|
dc.title |
The opioid overdose epidemic: opportunities for pharmacists. |
|
dc.type |
Journal article |
|
duke.contributor.id |
Wu, Li-Tzy|0380644 |
|
duke.contributor.id |
Mannelli, Paolo|0331498 |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/28814912 |
|
pubs.begin-page |
53 |
|
pubs.end-page |
55 |
|
pubs.organisational-group |
Center for Child and Family Policy |
|
pubs.organisational-group |
Clinical Science Departments |
|
pubs.organisational-group |
Duke |
|
pubs.organisational-group |
Duke Clinical Research Institute |
|
pubs.organisational-group |
Duke Institute for Brain Sciences |
|
pubs.organisational-group |
Institutes and Centers |
|
pubs.organisational-group |
Institutes and Provost's Academic Units |
|
pubs.organisational-group |
Medicine |
|
pubs.organisational-group |
Medicine, General Internal Medicine |
|
pubs.organisational-group |
Psychiatry & Behavioral Sciences |
|
pubs.organisational-group |
Psychiatry & Behavioral Sciences, Social and Community Psychiatry |
|
pubs.organisational-group |
Sanford School of Public Policy |
|
pubs.organisational-group |
School of Medicine |
|
pubs.organisational-group |
University Institutes and Centers |
|
pubs.publication-status |
Published online |
|
pubs.volume |
8 |
|
duke.contributor.orcid |
Wu, Li-Tzy|0000-0002-5909-2259 |
|